Lavipharm received an honorary distinction for its achievements in Research and Development.
During the closing ceremony of the Science, Technology and Innovation Exhibition that took place in Zappion Palace organised by the General Secretariat for Research and Technology, the Minister of Development Mr. Dimitris Sioufas awarded the companies which presented an increase to their investments in Research and Technological Development in 2006.
According to the European Industrial R&D Investment Scoreboard (European Table of Records in Research and Technological Development), Lavipharm is included among the leading 1.000 companies in the European Union that invest in this area and among the top 10 companies in Greece.
Today, Lavipharm holds a prominent position in pharmaceutical technology internationally. Focusing on the research of innovative drug delivery methods, it develops high technology products that are easy to use, decrease side effects, contribute in patients' compliance and substantially help them carry on a normal life. It applies its proprietary technologies in the development of products, either exclusively by the company or in cooperation with third parties, always aiming to the improvement of quality of Human life.
Lavipharm is an integrated Group of Companies that develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece, with a strong international activity.